Karmanos Cancer Institute is a clinical research site located in Detroit, Michigan, United States 48201.
Crixeo Clinical Trials Trust Score: 34/100 (FAILING). This profile has not yet been claimed by the site owner.
Karmanos Cancer Institute has participated in 524 clinical trials with 167 currently active.
Therapeutic areas: Non Small Cell Lung Cancer ALK Positive or ROS1 Positive, Acute Myeloid Leukemia, Primary Amyloidosis.
Sponsors: Pfizer, Telios Pharma, Inc., Prothena Biosciences Ltd..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Michigan · View every site in Detroit
Trust Score: 34/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Karmanos Cancer Institute has a Crixeo Trust Score of 34/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Karmanos Cancer Institute has 524 clinical trials on record, with 167 currently active. Their work covers Non Small Cell Lung Cancer ALK Positive or ROS1 Positive, Acute Myeloid Leukemia, Primary Amyloidosis.
Karmanos Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.